Inflammatory bowel disease (IBD), which affects millions of people worldwide, includes two
separate diseases: Crohn's disease (CD) and ulcerative colitis (UC). Although the …

Over 1 million residents in the USA and 2.5 million in Europe are estimated to have IBD, with
substantial costs for health care. These estimates do not factor in the'real'price of IBD, which …

In the 21st century, urbanization represents a major demographic shift in developed and
developing countries. Rapid urbanization in the developing world has been associated with …

IBD management often requires long-term treatment based on a combination of drugs to
control the disease. Clinicians should be aware of possible drug interactions and side …

The UK and China provide unique historical perspectives on the evolution of the incidence
of inflammatory bowel disease, which might provide insight into its pathogenesis. Historical …

Inflammatory bowel diseases (IBD) are characterized by chronic inflammation of the
intestinal mucosa and unknown etiology. In this review, we identified three main eras in the …

Objectives Microbiota dysbiosis in inflammatory bowel disease (IBD) has been widely
reported. The gut microbiota connect diet to the metabolism by producing small molecules …

Diet provides a safe and attractive alternative to available treatment options in a variety of
diseases; however, research has only just begun to elucidate the role of diet in chronic …

Abstract Background and Aims Group 3 innate lymphoid cells [ILC3s] sense environmental
signals and are critical in gut homeostasis and immune defence. G-protein-coupled …

Objective Previous studies have presented conflicting results on Western diets and the risk
of inflammatory bowel disease (IBD). This study aimed to evaluate the role of a pre‐illness …